March 30 (Reuters) - Knight Therapeutics Inc:
* KNIGHT THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR END 2019 RESULTS
* KNIGHT THERAPEUTICS - QTRLY LOSS PER SHARE $0.049 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.